PEOPLE - Nucryst Pharmaceuticals makes appointment:
This article was originally published in Clinica
Nucryst Pharmaceuticals, a Wakefield, Massachusetts-based company that specialises in nanocrystalline silver coatings for woundcare products (a range of which are marketed by Smith & Nephew), has appointed Thomas Gardner as chairman, president and CEO, effective immediately. Mr Gardner replaces Barry Heck (chairman), who remains as a director, and Scott Gillis (president and CEO), who is leaving the company.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.